Jing Jin
The University of Sydney(AU)Sun Yat-sen University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)National Medical Products Administration(CN)Peking Union Medical College Hospital(CN)National Cancer Center(US)Shanghai Institute of Materia Medica(CN)Yangzhou University(CN)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Breast Cancer Treatment Studies, Viral-associated cancers and disorders, MicroRNA in disease regulation, Gastric Cancer Management and Outcomes
Most-Cited Works
- → The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer(2019)852 cited
- → The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation(2020)794 cited
- → Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial(2019)392 cited
- → Radiotherapy As Primary Treatment for Stage IE and IIE Nasal Natural Killer/T-Cell Lymphoma(2005)357 cited
- → YTHDF1 Promotes Gastric Carcinogenesis by Controlling Translation of FZD7(2020)253 cited
- → METTL3 preferentially enhances non-m6A translation of epigenetic factors and promotes tumourigenesis(2022)129 cited